2015
DOI: 10.1002/prca.201400141
|View full text |Cite
|
Sign up to set email alerts
|

Proteomics of a conundrum: Thoughts on addressing the aetiology versus progression of multiple sclerosis

Abstract: Currently in the field of multiple sclerosis (MS) research there is an ongoing debate concerning the cause of the disease. MS is widely considered to begin with an autoimmune dysregulation. The disease does have a prominent autoimmune component however this may be representative of a secondary effect. There is growing evidence that the disease may be initiated by an underlying degeneration of oligodendrocytes. In our viewpoint, we discuss the potential differences between the aetiology and progression of MS. F… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
7
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 47 publications
1
7
0
Order By: Relevance
“…Due to the lack of clear concept for the aetiology of multiple sclerosis, clinical treatment strategies are limited to delaying progression of the disease by suppressing inflammation [27]. Recently, proteomic analysis of CPZ treated mice's brain samples was suggested as a potentially useful approach for finding therapeutic targets enabling causal treatment of the disease [28]. However, none of the previous studies [10][11][12] targeted the corpus callosum, where CPZinduces the most pronounced demyelination [13].…”
Section: Discussionmentioning
confidence: 99%
“…Due to the lack of clear concept for the aetiology of multiple sclerosis, clinical treatment strategies are limited to delaying progression of the disease by suppressing inflammation [27]. Recently, proteomic analysis of CPZ treated mice's brain samples was suggested as a potentially useful approach for finding therapeutic targets enabling causal treatment of the disease [28]. However, none of the previous studies [10][11][12] targeted the corpus callosum, where CPZinduces the most pronounced demyelination [13].…”
Section: Discussionmentioning
confidence: 99%
“…Currently, there are two competing theories regarding the pathophysiology underlying the initiation of Multiple Sclerosis (MS): ’outside-in‘ and ‘inside-out’ [1,2,3,4]. The former proposes that a dysregulated peripheral immune system leads to an autoimmune response against myelin components of the central nervous system (CNS).…”
Section: Introductionmentioning
confidence: 99%
“…Multiple Sclerosis (MS) is a heterogeneous, inflammatory demyelinating disease of the human central nervous system (CNS) for which the early initiating events and thus underlying etiology remain unclear (Stys et al, 2012;Stys, 2013;Partridge et al, 2015). Currently, there are no effective treatments to prevent disease initiation and progression (Sriram and Steiner, 2005;Vargas and Tyor, 2017).…”
Section: Introductionmentioning
confidence: 99%